Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
23 |
1848 |
1.763e-17 |
8.203e-14 |
2 |
IMMUNE SYSTEM DEVELOPMENT |
15 |
582 |
2.725e-15 |
6.339e-12 |
3 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
21 |
1805 |
5.054e-15 |
7.839e-12 |
4 |
LEUKOCYTE DIFFERENTIATION |
12 |
292 |
1.303e-14 |
1.516e-11 |
5 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
17 |
1004 |
1.983e-14 |
1.846e-11 |
6 |
POSITIVE REGULATION OF GENE EXPRESSION |
20 |
1733 |
4.187e-14 |
3.247e-11 |
7 |
CELL ACTIVATION |
14 |
568 |
5.584e-14 |
3.582e-11 |
8 |
RESPONSE TO LIPID |
16 |
888 |
6.158e-14 |
3.582e-11 |
9 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
20 |
1784 |
7.268e-14 |
3.758e-11 |
10 |
IMMUNE SYSTEM PROCESS |
20 |
1984 |
5.428e-13 |
2.526e-10 |
11 |
LEUKOCYTE ACTIVATION |
12 |
414 |
8.208e-13 |
3.234e-10 |
12 |
REGULATION OF CELL PROLIFERATION |
18 |
1496 |
8.34e-13 |
3.234e-10 |
13 |
POSITIVE REGULATION OF CELL PROLIFERATION |
14 |
814 |
7.304e-12 |
2.614e-09 |
14 |
MYELOID CELL DIFFERENTIATION |
9 |
189 |
1.154e-11 |
3.837e-09 |
15 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
16 |
1381 |
5.12e-11 |
1.588e-08 |
16 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
18 |
1929 |
6.069e-11 |
1.765e-08 |
17 |
CELLULAR RESPONSE TO LIPID |
11 |
457 |
6.587e-11 |
1.803e-08 |
18 |
LYMPHOCYTE ACTIVATION |
10 |
342 |
8.663e-11 |
2.239e-08 |
19 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
13 |
799 |
1.031e-10 |
2.351e-08 |
20 |
RESPONSE TO ENDOGENOUS STIMULUS |
16 |
1450 |
1.061e-10 |
2.351e-08 |
21 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
17 |
1710 |
1.052e-10 |
2.351e-08 |
22 |
REGULATION OF CELL DEATH |
16 |
1472 |
1.328e-10 |
2.809e-08 |
23 |
MYELOID LEUKOCYTE DIFFERENTIATION |
7 |
96 |
1.434e-10 |
2.902e-08 |
24 |
REGULATION OF CELL DIFFERENTIATION |
16 |
1492 |
1.624e-10 |
3.148e-08 |
25 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
16 |
1518 |
2.099e-10 |
3.899e-08 |
26 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
17 |
1791 |
2.179e-10 |
3.899e-08 |
27 |
RESPONSE TO HORMONE |
13 |
893 |
4.057e-10 |
6.991e-08 |
28 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
15 |
1395 |
7.622e-10 |
1.267e-07 |
29 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
16 |
1672 |
8.759e-10 |
1.359e-07 |
30 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
5 |
29 |
8.733e-10 |
1.359e-07 |
31 |
LYMPHOCYTE DIFFERENTIATION |
8 |
209 |
1.055e-09 |
1.583e-07 |
32 |
TUBE MORPHOGENESIS |
9 |
323 |
1.353e-09 |
1.968e-07 |
33 |
DENDRITIC CELL DIFFERENTIATION |
5 |
33 |
1.738e-09 |
2.367e-07 |
34 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
13 |
1008 |
1.781e-09 |
2.367e-07 |
35 |
LYMPHOID PROGENITOR CELL DIFFERENTIATION |
4 |
11 |
1.767e-09 |
2.367e-07 |
36 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
15 |
1492 |
1.933e-09 |
2.499e-07 |
37 |
POSITIVE REGULATION OF CELL COMMUNICATION |
15 |
1532 |
2.784e-09 |
3.409e-07 |
38 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
14 |
1275 |
2.714e-09 |
3.409e-07 |
39 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
5 |
40 |
4.779e-09 |
5.702e-07 |
40 |
HOMEOSTATIC PROCESS |
14 |
1337 |
5.009e-09 |
5.827e-07 |
41 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
14 |
5.341e-09 |
6.061e-07 |
42 |
REGULATION OF CELL CELL ADHESION |
9 |
380 |
5.598e-09 |
6.202e-07 |
43 |
LOCOMOTION |
13 |
1114 |
5.967e-09 |
6.457e-07 |
44 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
13 |
1135 |
7.471e-09 |
7.9e-07 |
45 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
11 |
724 |
8.355e-09 |
8.639e-07 |
46 |
MORPHOGENESIS OF AN EPITHELIUM |
9 |
400 |
8.739e-09 |
8.744e-07 |
47 |
TUBE DEVELOPMENT |
10 |
552 |
8.832e-09 |
8.744e-07 |
48 |
REGULATION OF CELL PROJECTION ORGANIZATION |
10 |
558 |
9.789e-09 |
9.296e-07 |
49 |
HOMEOSTASIS OF NUMBER OF CELLS |
7 |
175 |
9.745e-09 |
9.296e-07 |
50 |
EPITHELIUM DEVELOPMENT |
12 |
945 |
1.086e-08 |
9.717e-07 |
51 |
REGULATION OF CYTOKINE PRODUCTION |
10 |
563 |
1.066e-08 |
9.717e-07 |
52 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
11 |
740 |
1.048e-08 |
9.717e-07 |
53 |
REGULATION OF LIPID METABOLIC PROCESS |
8 |
282 |
1.11e-08 |
9.742e-07 |
54 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
5 |
48 |
1.233e-08 |
1.043e-06 |
55 |
REGULATION OF LIPID KINASE ACTIVITY |
5 |
48 |
1.233e-08 |
1.043e-06 |
56 |
PEPTIDYL TYROSINE MODIFICATION |
7 |
186 |
1.486e-08 |
1.235e-06 |
57 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
11 |
771 |
1.6e-08 |
1.306e-06 |
58 |
REGULATION OF RESPONSE TO STRESS |
14 |
1468 |
1.659e-08 |
1.331e-06 |
59 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
6 |
114 |
2.412e-08 |
1.902e-06 |
60 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
10 |
616 |
2.499e-08 |
1.927e-06 |
61 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
12 |
1021 |
2.567e-08 |
1.927e-06 |
62 |
TISSUE DEVELOPMENT |
14 |
1518 |
2.541e-08 |
1.927e-06 |
63 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
5 |
56 |
2.725e-08 |
2.013e-06 |
64 |
RESPONSE TO EXTERNAL STIMULUS |
15 |
1821 |
2.932e-08 |
2.132e-06 |
65 |
REGULATION OF CELL ADHESION |
10 |
629 |
3.043e-08 |
2.146e-06 |
66 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
8 |
321 |
3.036e-08 |
2.146e-06 |
67 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
11 |
823 |
3.13e-08 |
2.174e-06 |
68 |
REGULATION OF PROTEIN KINASE B SIGNALING |
6 |
121 |
3.449e-08 |
2.36e-06 |
69 |
CELL MOTILITY |
11 |
835 |
3.63e-08 |
2.413e-06 |
70 |
LOCALIZATION OF CELL |
11 |
835 |
3.63e-08 |
2.413e-06 |
71 |
INTRACELLULAR SIGNAL TRANSDUCTION |
14 |
1572 |
3.956e-08 |
2.593e-06 |
72 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
5 |
61 |
4.22e-08 |
2.727e-06 |
73 |
POSITIVE REGULATION OF KINASE ACTIVITY |
9 |
482 |
4.362e-08 |
2.78e-06 |
74 |
REGULATION OF PROTEIN ACETYLATION |
5 |
64 |
5.39e-08 |
3.389e-06 |
75 |
CELL PROLIFERATION |
10 |
672 |
5.668e-08 |
3.47e-06 |
76 |
NEGATIVE REGULATION OF CELL DEATH |
11 |
872 |
5.653e-08 |
3.47e-06 |
77 |
IMMUNE RESPONSE |
12 |
1100 |
5.845e-08 |
3.532e-06 |
78 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
5 |
67 |
6.805e-08 |
4.059e-06 |
79 |
EMBRYO DEVELOPMENT |
11 |
894 |
7.285e-08 |
4.291e-06 |
80 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
14 |
1656 |
7.623e-08 |
4.434e-06 |
81 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
11 |
905 |
8.249e-08 |
4.739e-06 |
82 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
12 |
1142 |
8.819e-08 |
5.004e-06 |
83 |
REGULATION OF IMMUNE SYSTEM PROCESS |
13 |
1403 |
9.278e-08 |
5.201e-06 |
84 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
11 |
917 |
9.43e-08 |
5.223e-06 |
85 |
RESPONSE TO CYTOKINE |
10 |
714 |
9.993e-08 |
5.47e-06 |
86 |
TISSUE MORPHOGENESIS |
9 |
533 |
1.029e-07 |
5.505e-06 |
87 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
11 |
926 |
1.041e-07 |
5.505e-06 |
88 |
POSITIVE REGULATION OF CELL ADHESION |
8 |
376 |
1.027e-07 |
5.505e-06 |
89 |
REGULATION OF ORGANELLE ORGANIZATION |
12 |
1178 |
1.238e-07 |
6.473e-06 |
90 |
PROTEIN PHOSPHORYLATION |
11 |
944 |
1.265e-07 |
6.541e-06 |
91 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
11 |
957 |
1.453e-07 |
7.428e-06 |
92 |
NEGATIVE REGULATION OF LOCOMOTION |
7 |
263 |
1.596e-07 |
8.07e-06 |
93 |
REGULATION OF DEFENSE RESPONSE |
10 |
759 |
1.765e-07 |
8.829e-06 |
94 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
4 |
32 |
1.88e-07 |
9.299e-06 |
95 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
8 |
408 |
1.919e-07 |
9.299e-06 |
96 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
11 |
983 |
1.904e-07 |
9.299e-06 |
97 |
PHOSPHORYLATION |
12 |
1228 |
1.947e-07 |
9.339e-06 |
98 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
6 |
163 |
2.032e-07 |
9.647e-06 |
99 |
REGULATION OF KINASE ACTIVITY |
10 |
776 |
2.167e-07 |
1.018e-05 |
100 |
REGULATION OF EPITHELIAL CELL MIGRATION |
6 |
166 |
2.263e-07 |
1.053e-05 |
101 |
RESPONSE TO FLUID SHEAR STRESS |
4 |
34 |
2.42e-07 |
1.093e-05 |
102 |
POSITIVE REGULATION OF LOCOMOTION |
8 |
420 |
2.393e-07 |
1.093e-05 |
103 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
5 |
86 |
2.402e-07 |
1.093e-05 |
104 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
7 |
285 |
2.75e-07 |
1.23e-05 |
105 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
289 |
3.022e-07 |
1.339e-05 |
106 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
36 |
3.066e-07 |
1.346e-05 |
107 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
11 |
1036 |
3.226e-07 |
1.39e-05 |
108 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
11 |
1036 |
3.226e-07 |
1.39e-05 |
109 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
7 |
296 |
3.552e-07 |
1.516e-05 |
110 |
REGULATION OF HOMEOSTATIC PROCESS |
8 |
447 |
3.841e-07 |
1.625e-05 |
111 |
REGULATION OF CELL DEVELOPMENT |
10 |
836 |
4.308e-07 |
1.806e-05 |
112 |
REGULATION OF HYDROLASE ACTIVITY |
12 |
1327 |
4.501e-07 |
1.87e-05 |
113 |
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION |
5 |
98 |
4.621e-07 |
1.886e-05 |
114 |
MYELOID LEUKOCYTE ACTIVATION |
5 |
98 |
4.621e-07 |
1.886e-05 |
115 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
13 |
1618 |
4.872e-07 |
1.971e-05 |
116 |
POSITIVE REGULATION OF CELL ACTIVATION |
7 |
311 |
4.955e-07 |
1.987e-05 |
117 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
8 |
465 |
5.179e-07 |
2.06e-05 |
118 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
4 |
41 |
5.242e-07 |
2.066e-05 |
119 |
REGULATION OF HEMOPOIESIS |
7 |
314 |
5.285e-07 |
2.066e-05 |
120 |
WOUND HEALING |
8 |
470 |
5.615e-07 |
2.177e-05 |
121 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
5 |
103 |
5.923e-07 |
2.205e-05 |
122 |
POSITIVE REGULATION OF DNA BINDING |
4 |
42 |
5.788e-07 |
2.205e-05 |
123 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
4 |
42 |
5.788e-07 |
2.205e-05 |
124 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
5 |
103 |
5.923e-07 |
2.205e-05 |
125 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
5 |
103 |
5.923e-07 |
2.205e-05 |
126 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
10 |
867 |
6.016e-07 |
2.222e-05 |
127 |
RESPONSE TO GROWTH FACTOR |
8 |
475 |
6.081e-07 |
2.228e-05 |
128 |
REGULATION OF MAPK CASCADE |
9 |
660 |
6.242e-07 |
2.269e-05 |
129 |
CELL FATE DETERMINATION |
4 |
43 |
6.374e-07 |
2.299e-05 |
130 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
10 |
876 |
6.612e-07 |
2.367e-05 |
131 |
REGULATION OF CELL ACTIVATION |
8 |
484 |
7.006e-07 |
2.488e-05 |
132 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
5 |
107 |
7.16e-07 |
2.524e-05 |
133 |
RESPONSE TO BIOTIC STIMULUS |
10 |
886 |
7.335e-07 |
2.566e-05 |
134 |
REGULATION OF INTERLEUKIN 8 BIOSYNTHETIC PROCESS |
3 |
12 |
8.105e-07 |
2.815e-05 |
135 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
6 |
207 |
8.277e-07 |
2.839e-05 |
136 |
EPITHELIAL CELL DIFFERENTIATION |
8 |
495 |
8.297e-07 |
2.839e-05 |
137 |
RESPONSE TO STEROID HORMONE |
8 |
497 |
8.553e-07 |
2.905e-05 |
138 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
11 |
1152 |
9.276e-07 |
3.105e-05 |
139 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
6 |
211 |
9.256e-07 |
3.105e-05 |
140 |
REGULATION OF SECRETION |
9 |
699 |
1.007e-06 |
3.347e-05 |
141 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
13 |
1.053e-06 |
3.473e-05 |
142 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
4 |
51 |
1.279e-06 |
4.192e-05 |
143 |
REGULATION OF TRANSFERASE ACTIVITY |
10 |
946 |
1.332e-06 |
4.32e-05 |
144 |
RESPONSE TO BACTERIUM |
8 |
528 |
1.346e-06 |
4.32e-05 |
145 |
RESPONSE TO LAMINAR FLUID SHEAR STRESS |
3 |
14 |
1.338e-06 |
4.32e-05 |
146 |
T CELL DIFFERENTIATION |
5 |
123 |
1.429e-06 |
4.555e-05 |
147 |
NEGATIVE REGULATION OF GENE EXPRESSION |
12 |
1493 |
1.583e-06 |
4.944e-05 |
148 |
EMBRYONIC MORPHOGENESIS |
8 |
539 |
1.571e-06 |
4.944e-05 |
149 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
7 |
370 |
1.583e-06 |
4.944e-05 |
150 |
POSITIVE REGULATION OF BINDING |
5 |
127 |
1.674e-06 |
5.193e-05 |
151 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
5 |
128 |
1.74e-06 |
5.362e-05 |
152 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
9 |
750 |
1.804e-06 |
5.524e-05 |
153 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
8 |
552 |
1.876e-06 |
5.669e-05 |
154 |
REGULATION OF ERK1 AND ERK2 CASCADE |
6 |
238 |
1.865e-06 |
5.669e-05 |
155 |
REGULATION OF NEURON DIFFERENTIATION |
8 |
554 |
1.928e-06 |
5.786e-05 |
156 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
4 |
57 |
2.008e-06 |
5.99e-05 |
157 |
POSITIVE REGULATION OF CELL CELL ADHESION |
6 |
243 |
2.103e-06 |
6.234e-05 |
158 |
RESPONSE TO WOUNDING |
8 |
563 |
2.173e-06 |
6.4e-05 |
159 |
GLAND DEVELOPMENT |
7 |
395 |
2.443e-06 |
7.149e-05 |
160 |
REGULATION OF CELLULAR LOCALIZATION |
11 |
1277 |
2.551e-06 |
7.418e-05 |
161 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
9 |
788 |
2.71e-06 |
7.784e-05 |
162 |
CIRCULATORY SYSTEM DEVELOPMENT |
9 |
788 |
2.71e-06 |
7.784e-05 |
163 |
LEUKOCYTE CELL CELL ADHESION |
6 |
255 |
2.78e-06 |
7.935e-05 |
164 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
7 |
404 |
2.835e-06 |
8.044e-05 |
165 |
REGULATION OF RESPONSE TO WOUNDING |
7 |
413 |
3.279e-06 |
9.246e-05 |
166 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
4 |
65 |
3.412e-06 |
9.563e-05 |
167 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
19 |
3.543e-06 |
9.813e-05 |
168 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
3 |
19 |
3.543e-06 |
9.813e-05 |
169 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
4 |
66 |
3.628e-06 |
9.988e-05 |
170 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
8 |
606 |
3.75e-06 |
0.0001026 |
171 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
5 |
152 |
4.05e-06 |
0.0001096 |
172 |
REGULATION OF CHROMATIN ORGANIZATION |
5 |
152 |
4.05e-06 |
0.0001096 |
173 |
MYELOID DENDRITIC CELL DIFFERENTIATION |
3 |
20 |
4.164e-06 |
0.000112 |
174 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
5 |
154 |
4.318e-06 |
0.0001155 |
175 |
ORGAN MORPHOGENESIS |
9 |
841 |
4.615e-06 |
0.000122 |
176 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
5 |
156 |
4.599e-06 |
0.000122 |
177 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
13 |
1977 |
4.724e-06 |
0.0001235 |
178 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
11 |
1360 |
4.7e-06 |
0.0001235 |
179 |
REGULATION OF GROWTH |
8 |
633 |
5.172e-06 |
0.0001344 |
180 |
REGULATION OF DEVELOPMENTAL GROWTH |
6 |
289 |
5.71e-06 |
0.0001476 |
181 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
7 |
452 |
5.932e-06 |
0.0001525 |
182 |
NEUROGENESIS |
11 |
1402 |
6.301e-06 |
0.0001602 |
183 |
REGULATION OF INFLAMMATORY RESPONSE |
6 |
294 |
6.299e-06 |
0.0001602 |
184 |
GLIAL CELL DEVELOPMENT |
4 |
76 |
6.386e-06 |
0.0001615 |
185 |
SINGLE ORGANISM CELL ADHESION |
7 |
459 |
6.56e-06 |
0.000165 |
186 |
TAXIS |
7 |
464 |
7.041e-06 |
0.0001761 |
187 |
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
3 |
24 |
7.36e-06 |
0.0001831 |
188 |
CELL DEVELOPMENT |
11 |
1426 |
7.416e-06 |
0.0001835 |
189 |
POSITIVE REGULATION OF MAPK CASCADE |
7 |
470 |
7.657e-06 |
0.0001856 |
190 |
VASCULATURE DEVELOPMENT |
7 |
469 |
7.551e-06 |
0.0001856 |
191 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
470 |
7.657e-06 |
0.0001856 |
192 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
6 |
304 |
7.626e-06 |
0.0001856 |
193 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
4 |
81 |
8.235e-06 |
0.0001985 |
194 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
3 |
25 |
8.355e-06 |
0.0002004 |
195 |
REGULATION OF CHEMOTAXIS |
5 |
180 |
9.235e-06 |
0.0002204 |
196 |
MYELOID DENDRITIC CELL ACTIVATION |
3 |
26 |
9.434e-06 |
0.000224 |
197 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
5 |
183 |
1.001e-05 |
0.0002358 |
198 |
REGULATION OF MAP KINASE ACTIVITY |
6 |
319 |
1.003e-05 |
0.0002358 |
199 |
POSITIVE REGULATION OF B CELL ACTIVATION |
4 |
86 |
1.045e-05 |
0.0002444 |
200 |
POSITIVE REGULATION OF HEART GROWTH |
3 |
27 |
1.06e-05 |
0.0002454 |
201 |
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS |
3 |
27 |
1.06e-05 |
0.0002454 |
202 |
LEUKOCYTE PROLIFERATION |
4 |
88 |
1.145e-05 |
0.0002625 |
203 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
4 |
88 |
1.145e-05 |
0.0002625 |
204 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
3 |
28 |
1.186e-05 |
0.0002705 |
205 |
REGULATION OF BODY FLUID LEVELS |
7 |
506 |
1.237e-05 |
0.0002808 |
206 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
3 |
29 |
1.322e-05 |
0.0002985 |
207 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
11 |
1517 |
1.338e-05 |
0.0003007 |
208 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
7 |
514 |
1.37e-05 |
0.0003064 |
209 |
REGULATION OF DNA BINDING |
4 |
93 |
1.426e-05 |
0.0003168 |
210 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
5 |
197 |
1.43e-05 |
0.0003168 |
211 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
4 |
94 |
1.488e-05 |
0.000328 |
212 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
6 |
343 |
1.515e-05 |
0.0003324 |
213 |
CANONICAL WNT SIGNALING PATHWAY |
4 |
95 |
1.551e-05 |
0.0003389 |
214 |
REGULATION OF ION HOMEOSTASIS |
5 |
201 |
1.575e-05 |
0.0003425 |
215 |
MACROPHAGE ACTIVATION |
3 |
31 |
1.622e-05 |
0.0003495 |
216 |
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY |
3 |
31 |
1.622e-05 |
0.0003495 |
217 |
REGULATION OF INTERFERON GAMMA PRODUCTION |
4 |
97 |
1.684e-05 |
0.0003612 |
218 |
CELL DEATH |
9 |
1001 |
1.878e-05 |
0.0004008 |
219 |
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
4 |
101 |
1.976e-05 |
0.0004199 |
220 |
HEART MORPHOGENESIS |
5 |
212 |
2.036e-05 |
0.0004306 |
221 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
5 |
213 |
2.083e-05 |
0.0004385 |
222 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
8 |
767 |
2.093e-05 |
0.0004386 |
223 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
6 |
364 |
2.118e-05 |
0.000442 |
224 |
HEART VALVE DEVELOPMENT |
3 |
34 |
2.153e-05 |
0.0004451 |
225 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
6 |
365 |
2.151e-05 |
0.0004451 |
226 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
7 |
554 |
2.22e-05 |
0.0004532 |
227 |
CARDIAC CHAMBER MORPHOGENESIS |
4 |
104 |
2.218e-05 |
0.0004532 |
228 |
POSITIVE REGULATION OF PROTEIN IMPORT |
4 |
104 |
2.218e-05 |
0.0004532 |
229 |
POSITIVE REGULATION OF SECRETION |
6 |
370 |
2.322e-05 |
0.0004719 |
230 |
REGULATION OF FAT CELL DIFFERENTIATION |
4 |
106 |
2.391e-05 |
0.0004819 |
231 |
BIOLOGICAL ADHESION |
9 |
1032 |
2.393e-05 |
0.0004819 |
232 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
5 |
220 |
2.433e-05 |
0.0004879 |
233 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
7 |
563 |
2.462e-05 |
0.0004917 |
234 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
6 |
375 |
2.505e-05 |
0.000498 |
235 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
3 |
36 |
2.563e-05 |
0.0005074 |
236 |
POSITIVE REGULATION OF B CELL PROLIFERATION |
3 |
37 |
2.786e-05 |
0.0005493 |
237 |
CELL FATE COMMITMENT |
5 |
227 |
2.827e-05 |
0.000555 |
238 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
8 |
801 |
2.857e-05 |
0.0005585 |
239 |
CYTOKINE SECRETION |
3 |
38 |
3.021e-05 |
0.0005858 |
240 |
POSITIVE REGULATION OF ORGAN GROWTH |
3 |
38 |
3.021e-05 |
0.0005858 |
241 |
REGULATION OF PROTEIN SECRETION |
6 |
389 |
3.076e-05 |
0.0005915 |
242 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
4 |
113 |
3.075e-05 |
0.0005915 |
243 |
REGULATION OF VASCULATURE DEVELOPMENT |
5 |
233 |
3.202e-05 |
0.0006132 |
244 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
3 |
39 |
3.27e-05 |
0.0006235 |
245 |
POSITIVE REGULATION OF GROWTH |
5 |
238 |
3.544e-05 |
0.0006731 |
246 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
4 |
118 |
3.644e-05 |
0.0006892 |
247 |
POSITIVE REGULATION OF CELL DEATH |
7 |
605 |
3.899e-05 |
0.0007315 |
248 |
POSITIVE REGULATION OF CHEMOTAXIS |
4 |
120 |
3.892e-05 |
0.0007315 |
249 |
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL |
3 |
42 |
4.094e-05 |
0.0007441 |
250 |
PEPTIDYL AMINO ACID MODIFICATION |
8 |
841 |
4.045e-05 |
0.0007441 |
251 |
CELL CELL ADHESION |
7 |
608 |
4.024e-05 |
0.0007441 |
252 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
4 |
121 |
4.021e-05 |
0.0007441 |
253 |
REGULATION OF B CELL ACTIVATION |
4 |
121 |
4.021e-05 |
0.0007441 |
254 |
REGULATION OF HEART GROWTH |
3 |
42 |
4.094e-05 |
0.0007441 |
255 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
7 |
609 |
4.066e-05 |
0.0007441 |
256 |
CALCIUM ION IMPORT INTO CYTOSOL |
3 |
42 |
4.094e-05 |
0.0007441 |
257 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
4 |
123 |
4.287e-05 |
0.0007732 |
258 |
ENDOCRINE SYSTEM DEVELOPMENT |
4 |
123 |
4.287e-05 |
0.0007732 |
259 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
7 |
616 |
4.372e-05 |
0.0007855 |
260 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
4 |
124 |
4.425e-05 |
0.0007919 |
261 |
KIDNEY EPITHELIUM DEVELOPMENT |
4 |
125 |
4.566e-05 |
0.000814 |
262 |
REGULATION OF IMMUNE RESPONSE |
8 |
858 |
4.663e-05 |
0.0008281 |
263 |
RESPONSE TO NITROGEN COMPOUND |
8 |
859 |
4.702e-05 |
0.0008318 |
264 |
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
3 |
45 |
5.044e-05 |
0.000889 |
265 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
4 |
129 |
5.164e-05 |
0.0009067 |
266 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
8 |
872 |
5.229e-05 |
0.0009148 |
267 |
CHEMICAL HOMEOSTASIS |
8 |
874 |
5.315e-05 |
0.0009262 |
268 |
RESPONSE TO DRUG |
6 |
431 |
5.449e-05 |
0.0009461 |
269 |
MAINTENANCE OF CELL NUMBER |
4 |
132 |
5.648e-05 |
0.000977 |
270 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
4 |
133 |
5.817e-05 |
0.001002 |
271 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
3 |
48 |
6.128e-05 |
0.001048 |
272 |
REGULATION OF MYOBLAST DIFFERENTIATION |
3 |
48 |
6.128e-05 |
0.001048 |
273 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
4 |
135 |
6.165e-05 |
0.001051 |
274 |
GLIAL CELL DIFFERENTIATION |
4 |
136 |
6.345e-05 |
0.001077 |
275 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
4 |
138 |
6.716e-05 |
0.001136 |
276 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
3 |
50 |
6.929e-05 |
0.001164 |
277 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
5 |
274 |
6.921e-05 |
0.001164 |
278 |
INFLAMMATORY RESPONSE |
6 |
454 |
7.267e-05 |
0.001216 |
279 |
REGULATION OF CHROMOSOME ORGANIZATION |
5 |
278 |
7.412e-05 |
0.001232 |
280 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
9 |
1192 |
7.405e-05 |
0.001232 |
281 |
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
3 |
52 |
7.796e-05 |
0.001291 |
282 |
CARDIAC CHAMBER DEVELOPMENT |
4 |
144 |
7.923e-05 |
0.001304 |
283 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
5 |
282 |
7.929e-05 |
0.001304 |
284 |
REGULATION OF BINDING |
5 |
283 |
8.062e-05 |
0.001321 |
285 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
3 |
53 |
8.255e-05 |
0.001338 |
286 |
CYTOSOLIC CALCIUM ION TRANSPORT |
3 |
53 |
8.255e-05 |
0.001338 |
287 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
3 |
53 |
8.255e-05 |
0.001338 |
288 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
7 |
684 |
8.465e-05 |
0.001368 |
289 |
CARTILAGE DEVELOPMENT |
4 |
147 |
8.583e-05 |
0.001381 |
290 |
POSITIVE REGULATION OF TRANSPORT |
8 |
936 |
8.61e-05 |
0.001381 |
291 |
DIGESTIVE SYSTEM DEVELOPMENT |
4 |
148 |
8.812e-05 |
0.001409 |
292 |
REGULATION OF CYTOKINE SECRETION |
4 |
149 |
9.045e-05 |
0.001436 |
293 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
7 |
691 |
9.023e-05 |
0.001436 |
294 |
REGULATION OF B CELL PROLIFERATION |
3 |
55 |
9.224e-05 |
0.00146 |
295 |
DEFENSE RESPONSE |
9 |
1231 |
9.495e-05 |
0.001498 |
296 |
REGULATION OF PROTEIN LOCALIZATION |
8 |
950 |
9.552e-05 |
0.001502 |
297 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
4 |
152 |
9.77e-05 |
0.001531 |
298 |
REGULATION OF CYTOPLASMIC TRANSPORT |
6 |
481 |
9.989e-05 |
0.00156 |
299 |
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS |
4 |
154 |
0.0001028 |
0.001594 |
300 |
POSITIVE REGULATION OF PEPTIDASE ACTIVITY |
4 |
154 |
0.0001028 |
0.001594 |
301 |
UROGENITAL SYSTEM DEVELOPMENT |
5 |
299 |
0.0001044 |
0.001614 |
302 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
4 |
156 |
0.000108 |
0.001653 |
303 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
4 |
156 |
0.000108 |
0.001653 |
304 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
4 |
156 |
0.000108 |
0.001653 |
305 |
REGULATION OF JNK CASCADE |
4 |
159 |
0.0001163 |
0.001774 |
306 |
REGULATION OF MONOOXYGENASE ACTIVITY |
3 |
60 |
0.0001197 |
0.001808 |
307 |
CHONDROCYTE DIFFERENTIATION |
3 |
60 |
0.0001197 |
0.001808 |
308 |
LEUKOCYTE HOMEOSTASIS |
3 |
60 |
0.0001197 |
0.001808 |
309 |
REGULATION OF INTERLEUKIN 8 PRODUCTION |
3 |
61 |
0.0001257 |
0.001869 |
310 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
4 |
162 |
0.000125 |
0.001869 |
311 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
4 |
162 |
0.000125 |
0.001869 |
312 |
HEMOSTASIS |
5 |
311 |
0.0001256 |
0.001869 |
313 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
4 |
162 |
0.000125 |
0.001869 |
314 |
REGULATION OF CYTOSKELETON ORGANIZATION |
6 |
502 |
0.0001262 |
0.001871 |
315 |
POSITIVE REGULATION OF HEMOPOIESIS |
4 |
163 |
0.000128 |
0.00189 |
316 |
CARDIAC VENTRICLE MORPHOGENESIS |
3 |
62 |
0.000132 |
0.001943 |
317 |
CARDIAC MUSCLE ADAPTATION |
2 |
11 |
0.0001352 |
0.001953 |
318 |
POSITIVE REGULATION OF CELL FATE COMMITMENT |
2 |
11 |
0.0001352 |
0.001953 |
319 |
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
2 |
11 |
0.0001352 |
0.001953 |
320 |
CARDIAC CHAMBER FORMATION |
2 |
11 |
0.0001352 |
0.001953 |
321 |
NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION |
2 |
11 |
0.0001352 |
0.001953 |
322 |
CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
2 |
11 |
0.0001352 |
0.001953 |
323 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
6 |
513 |
0.0001421 |
0.002047 |
324 |
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
3 |
64 |
0.0001451 |
0.002083 |
325 |
CALCIUM ION IMPORT |
3 |
65 |
0.0001519 |
0.002168 |
326 |
REGULATION OF CHEMOKINE PRODUCTION |
3 |
65 |
0.0001519 |
0.002168 |
327 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
4 |
172 |
0.0001574 |
0.002239 |
328 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
3 |
66 |
0.000159 |
0.002255 |
329 |
REGULATION OF VITAMIN METABOLIC PROCESS |
2 |
12 |
0.0001621 |
0.002285 |
330 |
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION |
2 |
12 |
0.0001621 |
0.002285 |
331 |
GLIOGENESIS |
4 |
175 |
0.0001682 |
0.002364 |
332 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
3 |
68 |
0.0001737 |
0.002435 |
333 |
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
3 |
69 |
0.0001814 |
0.00252 |
334 |
NEGATIVE REGULATION OF OSSIFICATION |
3 |
69 |
0.0001814 |
0.00252 |
335 |
POSITIVE REGULATION OF AXONOGENESIS |
3 |
69 |
0.0001814 |
0.00252 |
336 |
REGULATION OF DNA METABOLIC PROCESS |
5 |
340 |
0.0001904 |
0.002618 |
337 |
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY |
2 |
13 |
0.0001913 |
0.002618 |
338 |
REGULATION OF CELL FATE SPECIFICATION |
2 |
13 |
0.0001913 |
0.002618 |
339 |
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS |
2 |
13 |
0.0001913 |
0.002618 |
340 |
MESODERMAL CELL FATE COMMITMENT |
2 |
13 |
0.0001913 |
0.002618 |
341 |
REGULATION OF PROTEIN IMPORT |
4 |
183 |
0.0001996 |
0.002724 |
342 |
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE |
3 |
73 |
0.0002144 |
0.002876 |
343 |
ERYTHROCYTE HOMEOSTASIS |
3 |
73 |
0.0002144 |
0.002876 |
344 |
PANCREAS DEVELOPMENT |
3 |
73 |
0.0002144 |
0.002876 |
345 |
REGULATION OF ORGAN GROWTH |
3 |
73 |
0.0002144 |
0.002876 |
346 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
3 |
73 |
0.0002144 |
0.002876 |
347 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
6 |
552 |
0.0002115 |
0.002876 |
348 |
REGULATION OF PODOSOME ASSEMBLY |
2 |
14 |
0.000223 |
0.002968 |
349 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
74 |
0.0002233 |
0.002968 |
350 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
2 |
14 |
0.000223 |
0.002968 |
351 |
MESENCHYME DEVELOPMENT |
4 |
190 |
0.0002304 |
0.003055 |
352 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
5 |
360 |
0.0002481 |
0.003279 |
353 |
CONNECTIVE TISSUE DEVELOPMENT |
4 |
194 |
0.0002495 |
0.003289 |
354 |
CELLULAR CHEMICAL HOMEOSTASIS |
6 |
570 |
0.0002515 |
0.003305 |
355 |
HYALURONAN CATABOLIC PROCESS |
2 |
15 |
0.000257 |
0.003313 |
356 |
NEGATIVE REGULATION OF HISTONE ACETYLATION |
2 |
15 |
0.000257 |
0.003313 |
357 |
POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS |
2 |
15 |
0.000257 |
0.003313 |
358 |
INTERFERON GAMMA PRODUCTION |
2 |
15 |
0.000257 |
0.003313 |
359 |
POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
2 |
15 |
0.000257 |
0.003313 |
360 |
MUSCLE CELL FATE COMMITMENT |
2 |
15 |
0.000257 |
0.003313 |
361 |
RESPONSE TO ALCOHOL |
5 |
362 |
0.0002545 |
0.003313 |
362 |
RENAL TUBULE DEVELOPMENT |
3 |
78 |
0.0002609 |
0.003346 |
363 |
BLOOD VESSEL MORPHOGENESIS |
5 |
364 |
0.0002611 |
0.003346 |
364 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
4 |
197 |
0.0002645 |
0.003382 |
365 |
ION HOMEOSTASIS |
6 |
576 |
0.0002661 |
0.003392 |
366 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
3 |
79 |
0.0002709 |
0.003444 |
367 |
REGULATION OF ENDOCYTOSIS |
4 |
199 |
0.0002749 |
0.003476 |
368 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
5 |
368 |
0.0002746 |
0.003476 |
369 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
5 |
370 |
0.0002815 |
0.00355 |
370 |
CARDIAC RIGHT VENTRICLE MORPHOGENESIS |
2 |
16 |
0.0002935 |
0.003681 |
371 |
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE |
2 |
16 |
0.0002935 |
0.003681 |
372 |
RECEPTOR METABOLIC PROCESS |
3 |
82 |
0.0003024 |
0.003772 |
373 |
KIDNEY MORPHOGENESIS |
3 |
82 |
0.0003024 |
0.003772 |
374 |
REGULATION OF LEUKOCYTE PROLIFERATION |
4 |
206 |
0.0003136 |
0.003891 |
375 |
ORGAN REGENERATION |
3 |
83 |
0.0003134 |
0.003891 |
376 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
5 |
381 |
0.0003222 |
0.003987 |
377 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
3 |
84 |
0.0003246 |
0.004007 |
378 |
CARDIAC SEPTUM DEVELOPMENT |
3 |
85 |
0.0003361 |
0.004105 |
379 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
3 |
85 |
0.0003361 |
0.004105 |
380 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
3 |
85 |
0.0003361 |
0.004105 |
381 |
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
3 |
85 |
0.0003361 |
0.004105 |
382 |
POSITIVE REGULATION OF PROTEIN SECRETION |
4 |
211 |
0.0003434 |
0.004183 |
383 |
REGULATION OF TRANSPORT |
10 |
1804 |
0.0003511 |
0.004266 |
384 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
4 |
213 |
0.0003559 |
0.004313 |
385 |
REGULATION OF PEPTIDASE ACTIVITY |
5 |
392 |
0.0003671 |
0.004437 |
386 |
MYELOID CELL HOMEOSTASIS |
3 |
88 |
0.0003723 |
0.004467 |
387 |
REGULATION OF HETEROTYPIC CELL CELL ADHESION |
2 |
18 |
0.0003734 |
0.004467 |
388 |
CATECHOLAMINE BIOSYNTHETIC PROCESS |
2 |
18 |
0.0003734 |
0.004467 |
389 |
CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS |
2 |
18 |
0.0003734 |
0.004467 |
390 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
4 |
216 |
0.0003753 |
0.004478 |
391 |
RESPONSE TO ESTROGEN |
4 |
218 |
0.0003886 |
0.004601 |
392 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
4 |
218 |
0.0003886 |
0.004601 |
393 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
4 |
218 |
0.0003886 |
0.004601 |
394 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
3 |
90 |
0.0003977 |
0.004675 |
395 |
REGULATION OF INTRACELLULAR TRANSPORT |
6 |
621 |
0.0003979 |
0.004675 |
396 |
MESONEPHROS DEVELOPMENT |
3 |
90 |
0.0003977 |
0.004675 |
397 |
REGULATION OF INTERLEUKIN 5 PRODUCTION |
2 |
19 |
0.000417 |
0.004838 |
398 |
REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS |
2 |
19 |
0.000417 |
0.004838 |
399 |
THYMIC T CELL SELECTION |
2 |
19 |
0.000417 |
0.004838 |
400 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
2 |
19 |
0.000417 |
0.004838 |
401 |
ASTROCYTE DEVELOPMENT |
2 |
19 |
0.000417 |
0.004838 |
402 |
NEGATIVE REGULATION OF CELL ADHESION |
4 |
223 |
0.0004234 |
0.004901 |
403 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
5 |
406 |
0.0004311 |
0.004965 |
404 |
EMBRYONIC ORGAN DEVELOPMENT |
5 |
406 |
0.0004311 |
0.004965 |
405 |
NEPHRON EPITHELIUM DEVELOPMENT |
3 |
93 |
0.0004378 |
0.00503 |
406 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
4 |
228 |
0.0004604 |
0.005276 |
407 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
3 |
95 |
0.000466 |
0.005327 |
408 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
4 |
229 |
0.000468 |
0.005338 |
409 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
6 |
643 |
0.0004787 |
0.005446 |
410 |
CARDIOCYTE DIFFERENTIATION |
3 |
96 |
0.0004805 |
0.005453 |
411 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
4 |
232 |
0.0004916 |
0.005565 |
412 |
NECROPTOTIC PROCESS |
2 |
21 |
0.000511 |
0.00573 |
413 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
2 |
21 |
0.000511 |
0.00573 |
414 |
NEGATIVE REGULATION OF PROTEIN ACETYLATION |
2 |
21 |
0.000511 |
0.00573 |
415 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
3 |
98 |
0.0005104 |
0.00573 |
416 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
5 |
424 |
0.0005252 |
0.005875 |
417 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
3 |
100 |
0.0005414 |
0.006027 |
418 |
LIMBIC SYSTEM DEVELOPMENT |
3 |
100 |
0.0005414 |
0.006027 |
419 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
2 |
22 |
0.0005616 |
0.006192 |
420 |
REGULATION OF DOPAMINE SECRETION |
2 |
22 |
0.0005616 |
0.006192 |
421 |
REGULATION OF INTERLEUKIN 17 PRODUCTION |
2 |
22 |
0.0005616 |
0.006192 |
422 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
2 |
22 |
0.0005616 |
0.006192 |
423 |
REGULATION OF ORGAN MORPHOGENESIS |
4 |
242 |
0.0005761 |
0.006337 |
424 |
REGULATION OF CALCIUM ION IMPORT |
3 |
103 |
0.0005902 |
0.006477 |
425 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
3 |
104 |
0.0006071 |
0.006647 |
426 |
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
2 |
23 |
0.0006144 |
0.006649 |
427 |
SYNAPTIC VESICLE RECYCLING |
2 |
23 |
0.0006144 |
0.006649 |
428 |
REGULATION OF SUPEROXIDE METABOLIC PROCESS |
2 |
23 |
0.0006144 |
0.006649 |
429 |
STRIATED MUSCLE ADAPTATION |
2 |
23 |
0.0006144 |
0.006649 |
430 |
REGULATION OF GTPASE ACTIVITY |
6 |
673 |
0.000609 |
0.006649 |
431 |
CELLULAR HOMEOSTASIS |
6 |
676 |
0.0006235 |
0.006715 |
432 |
RESPONSE TO VIRUS |
4 |
247 |
0.000622 |
0.006715 |
433 |
CARDIAC VENTRICLE DEVELOPMENT |
3 |
106 |
0.0006418 |
0.006897 |
434 |
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION |
2 |
24 |
0.0006696 |
0.007179 |
435 |
REGULATION OF CELL CYCLE ARREST |
3 |
108 |
0.0006777 |
0.007249 |
436 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
6 |
689 |
0.0006891 |
0.007354 |
437 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
3 |
109 |
0.0006961 |
0.007412 |
438 |
FORMATION OF PRIMARY GERM LAYER |
3 |
110 |
0.0007149 |
0.007577 |
439 |
NEURON MIGRATION |
3 |
110 |
0.0007149 |
0.007577 |
440 |
SKELETAL SYSTEM DEVELOPMENT |
5 |
455 |
0.0007229 |
0.007645 |
441 |
LENS FIBER CELL DIFFERENTIATION |
2 |
25 |
0.0007271 |
0.007672 |
442 |
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
3 |
111 |
0.0007339 |
0.007691 |
443 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
4 |
258 |
0.0007322 |
0.007691 |
444 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
3 |
111 |
0.0007339 |
0.007691 |
445 |
LEUKOCYTE MIGRATION |
4 |
259 |
0.0007428 |
0.007767 |
446 |
ZYMOGEN ACTIVATION |
3 |
112 |
0.0007533 |
0.007859 |
447 |
REGULATION OF STEM CELL DIFFERENTIATION |
3 |
113 |
0.000773 |
0.008047 |
448 |
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
2 |
26 |
0.0007869 |
0.008047 |
449 |
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY |
2 |
26 |
0.0007869 |
0.008047 |
450 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
4 |
262 |
0.0007755 |
0.008047 |
451 |
REGULATION OF MESONEPHROS DEVELOPMENT |
2 |
26 |
0.0007869 |
0.008047 |
452 |
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
2 |
26 |
0.0007869 |
0.008047 |
453 |
POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE |
2 |
26 |
0.0007869 |
0.008047 |
454 |
MESODERMAL CELL DIFFERENTIATION |
2 |
26 |
0.0007869 |
0.008047 |
455 |
REGULATION OF CELL FATE COMMITMENT |
2 |
26 |
0.0007869 |
0.008047 |
456 |
POSITIVE REGULATION OF ENDOCYTOSIS |
3 |
114 |
0.000793 |
0.008057 |
457 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
3 |
114 |
0.000793 |
0.008057 |
458 |
REGULATION OF EMBRYONIC DEVELOPMENT |
3 |
114 |
0.000793 |
0.008057 |
459 |
HEAD DEVELOPMENT |
6 |
709 |
0.0008004 |
0.008113 |
460 |
HEART DEVELOPMENT |
5 |
466 |
0.000805 |
0.008142 |
461 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
3 |
115 |
0.0008134 |
0.008174 |
462 |
CELLULAR RESPONSE TO ALCOHOL |
3 |
115 |
0.0008134 |
0.008174 |
463 |
NEPHRON DEVELOPMENT |
3 |
115 |
0.0008134 |
0.008174 |
464 |
PROTEIN SECRETION |
3 |
116 |
0.0008341 |
0.008364 |
465 |
CELL PROLIFERATION IN FOREBRAIN |
2 |
27 |
0.000849 |
0.008423 |
466 |
EXCITATORY POSTSYNAPTIC POTENTIAL |
2 |
27 |
0.000849 |
0.008423 |
467 |
REGULATION OF HISTONE H3 K4 METHYLATION |
2 |
27 |
0.000849 |
0.008423 |
468 |
AXIS ELONGATION |
2 |
27 |
0.000849 |
0.008423 |
469 |
POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
2 |
27 |
0.000849 |
0.008423 |
470 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
5 |
472 |
0.0008526 |
0.00844 |
471 |
MAMMARY GLAND DEVELOPMENT |
3 |
117 |
0.0008551 |
0.008448 |
472 |
MESODERM DEVELOPMENT |
3 |
118 |
0.0008765 |
0.00864 |
473 |
REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY |
2 |
28 |
0.0009134 |
0.008873 |
474 |
NECROTIC CELL DEATH |
2 |
28 |
0.0009134 |
0.008873 |
475 |
REGULATION OF FIBROBLAST MIGRATION |
2 |
28 |
0.0009134 |
0.008873 |
476 |
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
2 |
28 |
0.0009134 |
0.008873 |
477 |
RESPONSE TO INORGANIC SUBSTANCE |
5 |
479 |
0.0009107 |
0.008873 |
478 |
MUSCLE HYPERTROPHY |
2 |
28 |
0.0009134 |
0.008873 |
479 |
REGULATION OF SPROUTING ANGIOGENESIS |
2 |
28 |
0.0009134 |
0.008873 |
480 |
CYTOKINE PRODUCTION |
3 |
120 |
0.0009202 |
0.00892 |
481 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
9 |
1676 |
0.0009481 |
0.009171 |
482 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
3 |
122 |
0.0009653 |
0.009318 |
483 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
2 |
29 |
0.0009801 |
0.009364 |
484 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
2 |
29 |
0.0009801 |
0.009364 |
485 |
PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
2 |
29 |
0.0009801 |
0.009364 |
486 |
REGULATION OF HEART MORPHOGENESIS |
2 |
29 |
0.0009801 |
0.009364 |
487 |
MUSCLE ADAPTATION |
2 |
29 |
0.0009801 |
0.009364 |
488 |
RESPONSE TO ABIOTIC STIMULUS |
7 |
1024 |
0.0009856 |
0.009397 |
489 |
INOSITOL LIPID MEDIATED SIGNALING |
3 |
124 |
0.001012 |
0.009627 |
490 |
SENSORY ORGAN DEVELOPMENT |
5 |
493 |
0.001036 |
0.009837 |
491 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
2 |
30 |
0.001049 |
0.009922 |
492 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
2 |
30 |
0.001049 |
0.009922 |